Roles of bone marrow cells in glomerular diseases

Clinical and Experimental Nephrology

Volumn 7, Issue 3, 2003, Pages 179-185

  Imasawa, Toshiyuki ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Bone marrow derived mesangial cells; Glomerular homeostasis; Glomerular remodeling; IgA nephropathy; Stem cell disease

Indexed keywords

GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GLOMERULAR HOMEOSTASIS; GLOMERULOPATHY; GLOMERULUS; HEMOSTASIS; HOMEOSTASIS; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; MACROMOLECULE; MESANGIUM; MOUSE; MOUSE STRAIN; NONHUMAN; REVIEW; STEM CELL; STEM CELL DISEASE; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; GLOMERULONEPHRITIS, IGA; HUMANS;

EID: 0141926505     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0248-9     Document Type: Review

References (59)

1. van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993;11:183-7.
2. Ikehara S. Intractable diseases and bone marrow transplantation. Pathol Int 1994;44:817-26.
3. Snowden JA, Biggs JC, Brooks PM. Autologous blood stem cell transplantation for autoimmune diseases. Lancet 1996;348:111-23.
4. Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo MM, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A 1985;82:2483-7.
5. Miyashima S, Nagata N, Nakagawa T, Hosaka N, Takeuchi K, Ogawa R, et al. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. J Immunol 1996;156:79-84.
6. Ikehara S, Yasumizu R, Inaba M, Izui S, Hayakawa K, Sekita K, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A 1989;86:3306-10.
7. Nishimura M, Toki J, Sugiura K, Hashimoto F, Tomita T, Fujishima H, et al. Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder. J Exp Med 1994;179:1053-8.
8. Adachi JD, Bensen WG, Kassam Y, Powers PJ, Bianchi FA, Cividino A, et al. Gold induced thrombocytopenia: 12 cases and a review of the literature. Semin Arthritis Rheum 1987;16:287-93.
9. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993;20:137-40.
10. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986;1:237-9.
11. Eedy DJ, Burrows D, Bridges JM, Jones FG. Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 1990;300:1398-9.
12. Yin JA. Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992;9:31-3.
13. Slavin S. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT. Bone Marrow Transplant 1993;12:85-8.
14. Brooks PM, Atkinson K, Hamilton JA. Stem cell transplantation in autoimmune disease. J Rheumatol 1995;22:1809-11.
15. Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, et al. Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999;24:729-34.
16. Lim SH, Kell J, al-Sabah A, Bashi W, Bailey-Wood R. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997;349:475.
17. Krance R, Brenner M. BMT beats autoimmune disease. Nat Med 1998;4:153-5.
18. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urot (Paris) 1968;74:694-5.
19. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-37.
20. Galla JH. IgA nephropathy. Kidney Int 1995;47:377-87.
21. Lai KN, To WY, Li PK, Leung JC. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int 1996;49:839-45.
22. Lai KN, Ho RT, Lai CK, Chan CH, Li PK. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol 1994;96:116-21.
23. de Caestecker MP, Bottomley M, Telfer BA, Hutchinson IV, Vose BM, Ballardie FW. Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int 1993;44:1298-308.
24. Rifai A, Schena FP, Montinaro V, Mele M, D'Addabbo A, Nitti L, et al. Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy. Lab Invest 1989;61:381-8.
25. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988;12:371-2.
26. Silva FG, Chander P, Pirani CL, Hardy MA. Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 1982;33:241-6.
27. Sakai O. IgA nephropathy: current concepts and future trends. Nephrology 1997;3:2-3.
28. Imasawa T, Utsunomiya Y, Kawamura T, Nagasawa R, Maruyama N, Sakai O. Evidence suggesting the involvement of hematopoietic stem cells in the pathogenesis of IgA nephropathy. Biochem Biophys Res Commun 1998;249:605-11.
29. Imasawa T, Nagasawa R, Utsunomiya Y, Kawamura T, Zhong Y, Makita N, et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int 1999;56:1809-17.
30. Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura AB. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1985;27:756-61.
31. Muso E, Yoshida H, Takeuchi E, Yashiro M, Matsushima H, Oyama A, et al. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int 1996;50:1946-57.
32. Muso E, Yoshida H, Takeuchi E, Shimada T, Yashiro M, Sugiyama T, et al. Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition. Clin Exp Immunol 1991;84:459-65.
33. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985;28:666-71.
34. Imasawa T, Utsunomiya Y, Zhong Y, Kawamura T, Nagasawa R, Okabe M, et al. Bone marrow as a potential source of glomerular mesangial cells (abstract). J Am Soc Nephrol 1999;10:406.
35. Imasawa T, Utsunomiya Y, Kawamura T, Zhong Y, Nagasawa R, Okabe M, et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 2001;12:1401-9.
36. Imasawa T, Utsunomiya Y. Stem cells in renal biology: bone marrow transplantation for the treatment of IgA nephropathy. Exp Nephrol 2002;10:51-8.
37. Gerson SL. Mesenchymal stem cells: no longer second class marrow citizens. Nat Med 1999;5:262-4.
38. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995;92:4857-61.
39. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-30.
40. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-70.
41. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-82.
42. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-72.
43. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8: 403-9.
44. Cornacchia F, Fornoni A, Plati AR, Thomas A, Wang Y, Inverardi L, et al. Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest 2001;108:1649-56.
45. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997;407:313-9.
46. Schreiner GF, Unanue ER. Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen. Lab Invest 1984;51:515-23.
47. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, Striker GE. Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 1988;33:677-84.
48. Kitamura M, Maruyama N, Yoshida H, Nagasawa R, Mitarai T, Sakai O. Extracellular matrix contraction by cultured mesangial cells: an assay system for mesangial cell-matrix interaction. Exp Mol Pathol 1991;54:181-200.
49. Ito T, Suzuki A, Imai E, Okabe M, Hori M. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001;12:2625-35.
50. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75.
51. Tack I, Elliot SJ, Potier M, Rivera A, Striker GE, Striker LJ. Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice. Diabetes 2002;51:182-8.
52. Mott JD, Khalifah RG, Nagase H, Shield CF 3rd, Hudson JK, Hudson BG. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int 1997;52:1302-12.
53. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000;11:574-81.
54. Uiker S, Kriz W. Structural analysis of the formation of glomerular microaneurysms in the Habu venom model. Virchows Arch 1995;426:281-93.
55. Haseley LA, Hugo C, Reidy MA, Johnson RJ. Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis. Kidney Int 1999;56:964-72.
56. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994;8:1888-96.
57. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 199;140:947-59.
58. Miner JH, Li C. Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev Biol 2000;217:278-89.
59. Masuya M, Drake CJ, Fleming PA, Reilly CM, Zeng H, Hill WD, et al. Hematopoietic origin of glomerular mesangial cells. Blood 2003;101:2215-8.